Citigroup’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $68.8K | Sell |
15,250
-13,268
| -47% | -$59.8K | ﹤0.01% | 3881 |
|
2025
Q1 | $126K | Sell |
28,518
-20,713
| -42% | -$91.8K | ﹤0.01% | 3701 |
|
2024
Q4 | $385K | Buy |
49,231
+21,872
| +80% | +$171K | ﹤0.01% | 3190 |
|
2024
Q3 | $360K | Buy |
27,359
+18,390
| +205% | +$242K | ﹤0.01% | 3194 |
|
2024
Q2 | $108K | Buy |
8,969
+2,224
| +33% | +$26.9K | ﹤0.01% | 3452 |
|
2024
Q1 | $110K | Buy |
6,745
+734
| +12% | +$11.9K | ﹤0.01% | 3519 |
|
2023
Q4 | $41K | Buy |
6,011
+5,992
| +31,537% | +$40.9K | ﹤0.01% | 3877 |
|
2023
Q3 | $103 | Sell |
19
-10,936
| -100% | -$59.3K | ﹤0.01% | 4640 |
|
2023
Q2 | $74.4K | Sell |
10,955
-35,887
| -77% | -$244K | ﹤0.01% | 3723 |
|
2023
Q1 | $235K | Buy |
46,842
+45,779
| +4,307% | +$229K | ﹤0.01% | 3035 |
|
2022
Q4 | $5.19K | Sell |
1,063
-93,217
| -99% | -$455K | ﹤0.01% | 4297 |
|
2022
Q3 | $1.36M | Buy |
94,280
+35,354
| +60% | +$510K | ﹤0.01% | 1883 |
|
2022
Q2 | $891K | Buy |
58,926
+28,524
| +94% | +$431K | ﹤0.01% | 2164 |
|
2022
Q1 | $361K | Sell |
30,402
-37,353
| -55% | -$444K | ﹤0.01% | 3060 |
|
2021
Q4 | $1.1M | Buy |
67,755
+35,999
| +113% | +$583K | ﹤0.01% | 2450 |
|
2021
Q3 | $906K | Sell |
31,756
-41,546
| -57% | -$1.19M | ﹤0.01% | 2463 |
|
2021
Q2 | $2.48M | Sell |
73,302
-23,651
| -24% | -$800K | ﹤0.01% | 1946 |
|
2021
Q1 | $2.93M | Buy |
96,953
+88,812
| +1,091% | +$2.69M | ﹤0.01% | 1700 |
|
2020
Q4 | $403K | Buy |
8,141
+4,712
| +137% | +$233K | ﹤0.01% | 2777 |
|
2020
Q3 | $132K | Sell |
3,429
-13,651
| -80% | -$525K | ﹤0.01% | 2994 |
|
2020
Q2 | $738K | Buy |
17,080
+570
| +3% | +$24.6K | ﹤0.01% | 2319 |
|
2020
Q1 | $431K | Sell |
16,510
-1,061
| -6% | -$27.7K | ﹤0.01% | 2368 |
|
2019
Q4 | $549K | Buy |
17,571
+16,276
| +1,257% | +$509K | ﹤0.01% | 2590 |
|
2019
Q3 | $34K | Sell |
1,295
-5,249
| -80% | -$138K | ﹤0.01% | 3974 |
|
2019
Q2 | $150K | Buy |
6,544
+4,685
| +252% | +$107K | ﹤0.01% | 3375 |
|
2019
Q1 | $49K | Buy |
1,859
+25
| +1% | +$659 | ﹤0.01% | 4037 |
|
2018
Q4 | $37K | Buy |
+1,834
| New | +$37K | ﹤0.01% | 4101 |
|